Without insurance, Zepbound costs an average of $1,559 for 4, 0.5 mL of 2.5 mg/0.5 mL pens (typically a one-month supply)
As of December 2024, the FDA approved tirzepatide for treatment of moderate-to-severe obstructive sleep apnea (OSA) in patients with obesity based on the results of two trials
Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosis
If nausea occurs, it typically appears within the first 1-2 hours after dosing and resolves within a few hours
Some focus on monthly medication management, while others bundle in nutritional counseling, body composition tracking, and regular follow-ups
Millions of Americansroughly 6% of the U.S